Publicacións nas que colabora con Fernando Alfonso Manterola (52)

2022

  1. Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e389-e396

  2. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2020

  1. Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: A pooled analysis of individual patient data

    EuroIntervention, Vol. 14, Núm. 16, pp. 1451-1457

  2. Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with st-segment elevation myocardial infarction: Vascular healing outcomes from the magstemi trial

    EuroIntervention, Vol. 16, Núm. 11, pp. E913-E921

2019

  1. MAGnesium-based bioresorbable scaffold and vasomotor function in patients with acute ST segment elevation myocardial infarction: The MAGSTEMI trial: Rationale and design

    Catheterization and Cardiovascular Interventions, Vol. 93, Núm. 1, pp. 64-70

  2. Magnesium-Based Resorbable Scaffold Versus Permanent Metallic Sirolimus-Eluting Stent in Patients with ST-Segment Elevation Myocardial Infarction: The MAGSTEMI Randomized Clinical Trial

    Circulation, Vol. 140, Núm. 23, pp. 1904-1916

2018

  1. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

2016

  1. Comparison of the Efficacy of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients with In-Stent Restenosis (from the RIBS IV and v Randomized Clinical Trials)

    American Journal of Cardiology, Vol. 117, Núm. 4, pp. 546-554

  2. Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)

    American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584

2015

  1. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial

    Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33

  2. Erratum: A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: The RIBS IV randomized clinical trial (Journal of the American College of Cardiology (2015) 66 (23-33))

    Journal of the American College of Cardiology

2014

  1. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS v clinical trial (restenosis intra-stent of bare metal stents: Paclitaxel-eluting balloon vs. everolimus-eluting stent)

    Journal of the American College of Cardiology, Vol. 63, Núm. 14, pp. 1378-1386

2013

  1. Sirolimus-eluting stent versus bare metal stent in diabetic patients: The final five-year follow-up of the DIABETES trial

    EuroIntervention, Vol. 9, Núm. 3, pp. 328-335

2012

  1. Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation. A report of the task force of the clinical practice guidelines committee of the Spanish society of cardiology

    Revista Espanola de Cardiologia, Vol. 65, Núm. 2, pp. 125-130

  2. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

    The Lancet, Vol. 380, Núm. 9852, pp. 1482-1490

2010

  1. Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation

    Circulation, Vol. 122, Núm. 10, pp. 1017-1025

2008

  1. Long-Term Clinical Benefit of Sirolimus-Eluting Stents in Patients With In-Stent Restenosis. Results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) Study

    Journal of the American College of Cardiology, Vol. 52, Núm. 20, pp. 1621-1627

2000

  1. Guidelines of the Spanish society of cardiology on interventional cardiology: Coronary angioplasty and other techniques

    Revista Espanola de Cardiologia, Vol. 53, Núm. 2, pp. 218-240

1994

  1. Angiographic changes (Dotter effect) produced by intravascular ultrasound imaging before coronary angioplasty

    American Heart Journal, Vol. 128, Núm. 2, pp. 244-251

  2. Early angiographic changes of side branches arising from a Palmaz-Sehatz stented coronary segment: Results and clinical implications

    Journal of the American College of Cardiology, Vol. 23, Núm. 4, pp. 911-915